87 related articles for article (PubMed ID: 15808673)
1. Augmentation of transgene expression in cold-preserved organs using vascular endothelial growth factor receptor-mediated adenoviral vector combined with hyperbaric oxygen.
Hayashi S; Liu DK; Yagi H; Takagi H; Nakao A
Transplant Proc; 2005; 37(1):450-2. PubMed ID: 15808673
[TBL] [Abstract][Full Text] [Related]
2. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.
Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH
Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802
[TBL] [Abstract][Full Text] [Related]
3. Adenoviral-mediated transfer of vascular endothelial growth factor 121 cDNA enhances myocardial perfusion and exercise performance in the nonischemic state.
Schalch P; Rahman GF; Patejunas G; Goldschmidt RA; Carbray J; Retuerto MA; Kim D; Esser K; Crystal RG; Rosengart TK
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):535-40. PubMed ID: 14762365
[TBL] [Abstract][Full Text] [Related]
4. Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expression.
Schowalter DB; Meuse L; Wilson CB; Linsley PS; Kay MA
Gene Ther; 1997 Aug; 4(8):853-60. PubMed ID: 9338015
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo and systemic transfer of adenovirus-mediated CTLA4Ig gene combined with a short course of FK506 therapy prolongs islet graft survival.
Akamaru Y; Ito T; Uchikoshi F; Maeda A; Tori M; Kiyomoto T; Komoda H; Miao G; Matsuda H
Transpl Immunol; 2003; 11(1):91-100. PubMed ID: 12727480
[TBL] [Abstract][Full Text] [Related]
6. Adenoviral-mediated gene transfer of ICP47 inhibits major histocompatibility complex class I expression on vascular cells in vitro.
Furukawa L; Brevetti LS; Brady SE; Johnson D; Ma M; Welling TH; Messina LM
J Vasc Surg; 2000 Mar; 31(3):558-66. PubMed ID: 10709070
[TBL] [Abstract][Full Text] [Related]
7. Combined gene therapy with adenovirus vectors containing CTLA4Ig and CD40Ig prolongs survival of composite tissue allografts in rat model.
Kanaya K; Tsuchida Y; Inobe M; Murakami M; Hirose T; Kon S; Kawaguchi S; Wada T; Yamashita T; Ishii S; Uede T
Transplantation; 2003 Feb; 75(3):275-81. PubMed ID: 12589145
[TBL] [Abstract][Full Text] [Related]
8. Influence of temperature on adenovirus-mediated gene transfer.
Pellegrini C; O'Brien T; Jeppsson A; Fitzpatrick LA; Yap J; Tazelaar HD; McGregor CG
Eur J Cardiothorac Surg; 1998 May; 13(5):599-603. PubMed ID: 9663545
[TBL] [Abstract][Full Text] [Related]
9. Immunity to islet grafts transduced with adenovirus vectors does not inhibit long-term islet function.
Cheng J; Sun J; Sung RS
Transpl Immunol; 2009 May; 21(1):33-42. PubMed ID: 19224710
[TBL] [Abstract][Full Text] [Related]
10. Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig.
Jooss K; Turka LA; Wilson JM
Gene Ther; 1998 Mar; 5(3):309-19. PubMed ID: 9614550
[TBL] [Abstract][Full Text] [Related]
11. Efficiency of adenoviral vector mediated CTLA4Ig gene delivery into mesenchymal stem cells.
Deng Y; Guo X; Yuan Q; Li S
Chin Med J (Engl); 2003 Nov; 116(11):1649-54. PubMed ID: 14642129
[TBL] [Abstract][Full Text] [Related]
12. CTLA4Ig delivered by high-capacity adenoviral vector induces stable expression of dystrophin in mdx mouse muscle.
Jiang Z; Schiedner G; Gilchrist SC; Kochanek S; Clemens PR
Gene Ther; 2004 Oct; 11(19):1453-61. PubMed ID: 15269713
[TBL] [Abstract][Full Text] [Related]
13. Effects of interleukin-12p40 gene transfer on rat corneal allograft survival.
Ritter T; Yang J; Dannowski H; Vogt K; Volk HD; Pleyer U
Transpl Immunol; 2007 Nov; 18(2):101-7. PubMed ID: 18005852
[TBL] [Abstract][Full Text] [Related]
14. Effect of combined OX40Ig and CTLA4Ig gene local transfer on allograft rejection and the underlying mechanisms.
Zhang J; Miao Q; Yang Y; Xiao B; Liu B; Cao J; Hao XY; Wang SW; Guo SZ
J Surg Res; 2012 Dec; 178(2):949-58. PubMed ID: 22694937
[TBL] [Abstract][Full Text] [Related]
15. Efficient adenoviral gene transfer to kidney cortical vasculature utilizing a fiber modified vector.
McDonald GA; Zhu G; Li Y; Kovesdi I; Wickham TJ; Sukhatme VP
J Gene Med; 1999; 1(2):103-10. PubMed ID: 10738574
[TBL] [Abstract][Full Text] [Related]
16. Cre/loxP-mediated CTLA4IgG gene transfer induces clinically relevant immunosuppression via on-off gene recombination in vivo.
Izawa A; Sano K; Takehara M; Inobe M; Suzuki J; Imamura H; Takahashi M; Ikeda U; Isobe M; Uede T
Cardiovasc Res; 2006 Jan; 69(1):289-97. PubMed ID: 16185671
[TBL] [Abstract][Full Text] [Related]
17. Long-term acceptance of rat cardiac allografts on the basis of adenovirus mediated CD40Ig plus CTLA4Ig gene therapies.
Yamashita K; Masunaga T; Yanagida N; Takehara M; Hashimoto T; Kobayashi T; Echizenya H; Hua N; Fujita M; Murakami M; Furukawa H; Uede T; Todo S
Transplantation; 2003 Oct; 76(7):1089-96. PubMed ID: 14557758
[TBL] [Abstract][Full Text] [Related]
18. Improved vascular gene transfer with a helper-dependent adenoviral vector.
Wen S; Graf S; Massey PG; Dichek DA
Circulation; 2004 Sep; 110(11):1484-91. PubMed ID: 15326058
[TBL] [Abstract][Full Text] [Related]
19. A mouse model of arterial gene transfer: antigen-specific immunity is a minor determinant of the early loss of adenovirus-mediated transgene expression.
Vassalli G; Agah R; Qiao R; Aguilar C; Dichek DA
Circ Res; 1999 Oct; 85(9):e25-32. PubMed ID: 10532959
[TBL] [Abstract][Full Text] [Related]
20. Low-dose etoposide enhances telomerase-dependent adenovirus-mediated cytosine deaminase gene therapy through augmentation of adenoviral infection and transgene expression in a syngeneic bladder tumor model.
Shieh GS; Shiau AL; Yo YT; Lin PR; Chang CC; Tzai TS; Wu CL
Cancer Res; 2006 Oct; 66(20):9957-66. PubMed ID: 17047058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
